Is Diamond Hill’s New Stake Reframing Knowles (KN) As A Mission-Critical Margin Story?

• In the first quarter of 2026, Diamond Hill Capital initiated a new position in Knowles Corporation within its Small Cap Strategy, highlighting the company’s pivot toward higher-margin, mission-critical medical, defense, and industrial end markets.
• An interesting angle is that Diamond Hill believes Knowles’ current market valuation does not yet reflect its improved business mix and long-term growth potential, suggesting a possible disconnect between fundamentals and investor perception.
• We’ll now examine how Diamond Hill’s endorsement of Knowles’ higher-margin, mission-critical focus reshapes the company’s existing investment narrative.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

Knowles Investment Narrative Recap

To own Knowles, you have to believe its shift toward higher margin, mission critical medical, defense, and industrial products can support resilient earnings, even if top line growth stays moderate. The biggest near term catalyst remains execution on newer product lines and factory efficiency, while the key risk is further margin pressure from product mix and ramp up costs. Diamond Hill’s new position reinforces the thesis around mix improvement but does not materially change those immediate risks or catalysts.

The recent Q1 2026 results, with revenue of US$153.1 million and a return to net income of US$9.7 million, give fresh context to Diamond Hill’s move. Solid earnings and confirmed Q2 guidance help support the idea that Knowles’ higher margin focus is gaining traction, but they also put a spotlight on whether the company can keep scaling specialty film and inductors without reigniting scrap costs and production inefficiencies that could blunt future margin gains.

Yet against this improving story, investors should still watch the risk that persistent factory inefficiencies and product mix headwinds could...

Read the full narrative on Knowles (it's free!)

Knowles' narrative projects $716.9 million revenue and $122.3 million earnings by 2029. This requires 6.5% yearly revenue growth and a $71.4 million earnings increase from $50.9 million today.

Uncover how Knowles' forecasts yield a $28.50 fair value, a 16% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts paint a far more cautious picture, even while forecasting revenue of about US$657.5 million and earnings near US$158.6 million by 2028, which shows just how differently you can interpret the same business and why Diamond Hill’s new position might eventually shift those expectations in more than one direction.

Explore 2 other fair value estimates on Knowles - why the stock might be worth as much as 15% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Knowles research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Knowles research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Knowles' overall financial health at a glance.

Interested In Other Possibilities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• Capitalize on the AI infrastructure supercycle with our selection of the 40 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com